This inventor holds 23 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 2 EPO patents, primarily in Amyloid Disease Treatment. Top assignees: Queen's University at Kingston, Treventis Corporation, Bellus Health (International) Limited. Active years: 1997-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kingston, CA (1997 - 2008)
- Halifax, CA (2006 - 2023)
Company Filing History:
15 out of 424 
3 out of 6 
2 out of 3 Years Active: 1997-2023
Areas of Expertise:
Title: **The Innovative Contributions of Donald F. Weaver**
Introduction
Donald F. Weaver is a notable inventor based in Halifax, Canada, recognized for his impactful contributions in the field of neuroscience and biochemistry. With an impressive portfolio of 23 patents, Weaver's work focuses on methodologies that advance understanding and treatment of neurological conditions, particularly regarding amyloid protein aggregation and cognitive function assessment.
Latest Patents
Among his recent patents, Weaver has developed innovative methods for identifying inhibitors of amyloid protein aggregation. This patent describes techniques for recognizing compounds that can inhibit or potentially inhibit amyloid aggregation, along with the creation of three-dimensional, non-crystallographic models, known as 'pseudo-crystal structures', which are pivotal in these methods. Another significant patent is related to cognitive function assessment in patients. This invention outlines a comprehensive approach to analyze a patient’s conscious awareness and potential for recovery by employing a sensory stimulus sequence and performing EEG analysis to capture neural activity.
Career Highlights
Donald F. Weaver has had an impactful career, contributing substantially to the field of medical research. He has worked at notable institutions such as Queen's University at Kingston and Treventis Corporation, where he focused on the intersection of research and practical applications in neuroscience.
Collaborations
Weaver has collaborated with esteemed colleagues including Walter A. Szarek and Richard J. Riopelle. Their joint efforts have furthered research and innovations in understanding complex neurological conditions and developing therapeutic strategies.
Conclusion
In conclusion, Donald F. Weaver’s innovative work and extensive patent portfolio reflect his dedication to advancing medical science and improving patient outcomes. His contributions, particularly in the areas of amyloid protein research and cognitive assessments, are a testament to his significant role within the scientific community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile